Vanda Pharmaceuticals VNDA
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 8.82 | 106.19 | -2.39 | -40,353 | -141 | |
| 2025Q3 | 4.99 | -0.38 | -31,284 | -23 | ||
| 2025Q2 | 4.72 | -0.46 | -38,503 | -27 | ||
| 2025Q1 | 4.59 | 109.79 | -0.50 | -41,028 | -29 | |
| 2024Q4 | 4.79 | 158.21 | -0.09 | -10,279 | -5 | |
| 2024Q3 | 4.69 | 176.17 | -0.09 | -11,000 | -5 | |
| 2024Q2 | 5.65 | 183.94 | -0.08 | -10,146 | -5 | |
| 2024Q1 | 4.11 | 198.01 | 94.25 | -0.07 | -9,235 | -4 |
| 2023Q4 | 4.22 | 427.09 | 20.63 | -0.05 | -7,094 | -2 |
| 2023Q3 | 4.32 | 4995.83 | 16.67 | 0.01 | -5,995 | 0 |
| 2023Q2 | 6.59 | -110.61 | 23.72 | 0.02 | -2,867 | 2 |
| 2023Q1 | 6.79 | 36.25 | 61.45 | 0.06 | 2,004 | 3 |
| 2022Q4 | 7.39 | 68.96 | 64.42 | 0.12 | 6,629 | 7 |
| 2022Q3 | 9.88 | 71.56 | 50.83 | 0.06 | 3,908 | 3 |
| 2022Q2 | 10.90 | 91.32 | 34.07 | 0.04 | 3,461 | 3 |
| 2022Q1 | 11.31 | 101.39 | 19.07 | -0.11 | -7,669 | -6 |
| 2021Q4 | 15.69 | 100.30 | 0.12 | 8,636 | 7 | |
| 2021Q3 | 17.14 | 100.90 | 30.27 | 0.14 | 10,819 | 8 |
| 2021Q2 | 21.51 | 98.14 | 37.94 | 0.17 | 12,369 | 10 |
| 2021Q1 | 15.02 | 99.17 | 35.32 | 0.15 | 10,341 | 9 |